Print ISSN:-2581-5024

Online ISSN:-2581-5016


Current Issue

Year 2020

Volume: 6 , Issue: 2

Article Access statistics

Viewed: 633

Emailed: 0

PDF Downloaded: 162

IP International Journal of Ocular Oncology and Oculoplasty

Dazzling and sparkling eyes in ladies: boon or bane in ophthalmology

Full Text PDF Share on Facebook Share on Twitter

Author Details : Sasmita Sahu, Swati Samikshya, Sarmistha Behera, Anuradha Pradhan, K.C. Tudu

Volume : 3, Issue : 3, Year : 2017

Article Page : 219-225

Suggest article by email


Aim of Study: To study the prevalence, demographic factors, clinical features, examination, diagnosis and treatment outcome of Thyroid Eye Disease (TED).
Introduction: Graves’s disease(GD) is the commonest autoimmune disorder affecting the thyroid gland which involves soft tissues of periorbital space, extraocular muscles and orbit. TED can be sight threatening besides its cosmetic effects. The manifestations can be effectively investigated and judiciously treated with antithyroid drugs and corticosteroid and surgery.
Materials and Methods: This Prospective study was done on 60 consecutive patients with Graves disease, relevant history was taken, thorough ocular examinations and investigations were done. All patients with thyroid ophthalmopathy were under antithyroid treatment.
Result: Out of 60 hyperthyroid patients, 27 presented with Grave’s Ophthalmopathy (GO), with female: male ratio of 8:1. 59.2% presented as moderate to severe GO, 37% mild, and only 1% had sight threatening GO. Upper lid retraction was the commonest presentation (100%) followed by proptosis (70.3%) and exposure keratitis (51.8%). Treatment given to patient based on current protocol was quite effective in maximum cases.

Thyroid Eye Disease (TED), Grave’s Ophthalmopathy (GO), Upper Lid Retraction, Proptosis

How to cite : Sahu S, Samikshya S, Behera S, Pradhan A, Tudu K, Dazzling and sparkling eyes in ladies: boon or bane in ophthalmology. IP Int J Ocul Oncol Oculoplasty 2017;3(3):219-225

Copyright © 2017 by author(s) and IP Int J Ocul Oncol Oculoplasty. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (